GeneFrontier to Make, Market Abcellute's Hepatocyte Tech to Japanese Drug Makers | GenomeWeb
NEW YORK (GenomeWeb News) — Welsh research company Abcellute today said it has signed an exclusive deal with microarray service provider GeneFrontier to manufacture, market, and distribute Abcellute’s hepatocyte cell-preservation products in Japan.
 
The agreement also gives Tokyo-based GeneFrontier rights to pen sub-license deals with the technology with pharma companies.    
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.